A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. - Test2 - elhamkhani - TriplyDB

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

http://www.wikidata.org/entity/Q33727402

about

Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica Neuromyelitis optica pathogenesis and aquaporin 4 Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab Aquaporin 4 and neuromyelitis optica Theiler's virus infection: a model for multiple sclerosis Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis Demyelinating diseases Human Aquaporin-4 and Molecular Modeling: Historical Perspective and View to the Future Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation What do we know about brain contrast enhancement patterns in neuromyelitis optica?Hypersensitivity Responses in the Central Nervous System Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management Update on biomarkers in neuromyelitis optica Development, maintenance and disruption of the blood-brain barrier Applications of SPR for the characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseases Membrane attack by complement: the assembly and biology of terminal complement complexes Immunology of neuromyelitis optica: a T cell-B cell collaboration Molecular pathogenesis of neuromyelitis optica Conventional and advanced imaging in neuromyelitis optica Is Multiple Sclerosis an Autoimmune Disease?A treatment of neuromyelitis optica (Devic's disease) during pregnancy Treatment of neuromyelitis optica: state-of-the-art and emerging therapies Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate The astrocyte in multiple sclerosis revisited The immunopathology of multiple sclerosis: an overview Pathology of multiple sclerosis: where do we stand?Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?Oligodendrocytes: biology and pathology Bilateral Internuclear Ophthalmoplegia in a Patient with Devic's Neuromyelitis Optica.Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.

P2860

Q21132530-E563D630-8944-432A-A5AE-99277B997177 Q21144670-D75D60AD-7667-42E7-80BF-8342DD83B353 Q21245240-069F4851-D471-41D8-B27A-C1FCFA4930A2 Q21558554-F969BB3B-3177-4E3C-8D1F-45C58A79BDFE Q24598109-69FCA03A-F243-4165-9A85-965071E17168 Q24613666-B1B6D716-6BE6-47FA-BF78-07896466F953 Q24629115-44E889CF-B954-49D2-8BDD-A4049BDDFBAB Q24642895-DED12C2C-EBD1-473E-9ABC-ED7DC37149D7 Q24646531-446FA2C2-4B39-445A-BC5F-13828976F6B6 Q24650437-7783A6B8-64FF-468B-90A5-3CD6C7B4F4D5 Q24676347-34F827DF-B251-4EE2-B83C-F431AD18AD92 Q26740107-049A6FEC-BA02-408B-8329-5064AA354C48 Q26748229-947D37B2-12A0-4AD3-9B6E-E06C76189F09 Q26767391-3126796F-1CEF-4632-A0CB-5AD686CF7976 Q26770852-8E3496AC-DBA6-49B1-B33A-504B0EDCF723 Q26776278-4B4D9D9B-2507-49A2-BF91-0C0FADC7FF0A Q26779177-C5FD16CC-2409-4281-AEE3-DD75740D1D3A Q26796643-14A95E75-9A6C-441A-94A5-7C02ABE1B6AB Q26799789-8DC4A3F6-5707-46B2-B910-83E41ACF6689 Q26829668-DFE55176-7320-497E-A484-EB9FC514C57D Q26860077-8A9E2F4B-6F26-41A6-B234-8001E23E2EEF Q26997385-E9FFEDF5-C280-4A07-B704-457ED02E907D Q27016045-216E4F6C-4B45-41D2-9975-9001150DCE11 Q27021535-141AFE60-612A-4FA0-8FC1-2766A9D87E3C Q27021822-939EC3DD-58C1-4C50-884F-A6E5B83CB28C Q27496011-9A00DE78-860D-4EA9-B30E-93040254C1A5 Q28067384-7818B17A-C396-454D-89E2-BC1EBD308E31 Q28245749-1983CE8B-D40A-4852-B617-526AEAA64410 Q28246073-EAA1A185-1DD1-4205-B692-80E75C73A15C Q28267527-50EA026A-3FC3-4899-9DA2-710097A39A8E Q28276365-713FF182-A331-4FB2-B49A-047FC2DEFD49 Q28283441-C3EB26A7-1729-4ADF-912E-5A9CC26AE860 Q28295115-D54AB014-0BA7-4F74-9E17-D7F5D93CA739 Q28296052-04094E5C-25E7-400A-AE05-C8DB3BD36FE6 Q28301662-12207992-8A2D-471D-A3BA-864632E392AA Q28552020-414E46D1-53D3-4838-81A9-EEF410D4F092 Q29042454-90B14423-1BD6-4E5E-8C89-E72F00D5ED08 Q30051584-3839C228-70E6-4E9E-B454-B6BD81AF51C5 Q30497428-6FFFF304-A299-4FC1-A33F-43CD3BFBA064 Q30577078-FC83572C-33AB-4E23-8C80-4D715D5EED69

P2860

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

http://www.wikidata.org/entity/Q33727402

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

@ast

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

@en

type

label

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

@ast

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

@en

prefLabel

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

@ast

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

@en

P1433

Q33727402-47E45378-A9D5-44BA-9D98-E59AADD1A762

P1476

Q33727402-41557BA0-9A33-4465-939B-DFAE3835E0F7

P2093

Q33727402-11D21083-722A-4C91-B6FF-5544B63FD703

Q33727402-1E8FA367-204D-4A47-BE53-1405A285BFD2

Q33727402-22689B93-154B-4FD6-A79D-5837B966935C

Q33727402-2A93CFDB-B219-4424-B128-F5F0498F1EC1

Q33727402-370EE3A3-2845-4822-8777-E5D7A576F349

Q33727402-A4FE3B41-9765-405B-8498-9EE2C11E3D46

Q33727402-B67D0B6F-0BC1-41F3-92B4-438E57316372

Q33727402-C7960D1E-7BBA-4B14-B238-7EB5A6DCC36D

Q33727402-F4E468FB-466E-4C02-862A-1DEAC0187C60

P2860

Q33727402-0A92DB77-CEB2-41F9-A60E-5E0AFE471BC0

Q33727402-175E911C-587C-4D9C-84CA-980018369ABF

Q33727402-1B220D77-51CD-4ADE-AE46-7ED4CDD33DC3

Q33727402-1C41E3BB-E2AC-4054-85B8-1FE3AF58035D

Q33727402-2AA0B91E-2172-4744-8748-18E950528E5B

Q33727402-2E649561-2E1B-497C-AAEA-C3E32149A44F

Q33727402-2E933BE1-6977-4A5E-952E-88B02CA0D4B0

Q33727402-37F2599E-D6EC-4A0A-A612-977B300017CC

Q33727402-451B5DC0-0761-4040-B373-AADB58E0C269

Q33727402-4AE48AD9-97A1-407E-A893-823FC64F8825

P304

Q33727402-FA197B98-E6FE-4ABB-8A2D-038A0BA5DE1B

P31

Q33727402-56471B85-F0BD-4F72-BCD9-79C39BC71F28

P356

Q33727402-52DBD539-9AC1-4D6D-B6E7-A07572F43B14

P407

Q33727402-96B9F3C0-5477-41A8-8A73-26DAA6A59E0D

P433

Q33727402-3E589D7D-9FC7-4239-B37A-74139B01D581

P478

Q33727402-D5B9D134-84BA-4CEB-A086-72354E053058

P50

Q33727402-02E25BB5-A7BD-48F3-A10C-7C7859CEF1D5

Q33727402-AA543FAF-99C4-4D94-9A1F-34D11A47506E

P577

Q33727402-044B393A-4413-4C3B-9AFE-38F6336C45E8

P698

Q33727402-7DA20367-0242-4ED5-8B3A-1027F6C6CFE6

P921

Q33727402-CD8374B8-10BC-4435-83E4-2F6D71DC0862

P932

Q33727402-845A27CB-2330-41D3-96F4-8C79D9DA4F7E

P356

P1433

P1476

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

@en

P2093

Brian Weinshenker

http://www.w3.org/2001/XMLSchema#string

Claudia F Lucchinetti

http://www.w3.org/2001/XMLSchema#string

Corinna Trebst

http://www.w3.org/2001/XMLSchema#string

Dean Wingerchuk

http://www.w3.org/2001/XMLSchema#string

Gerald Gleich

http://www.w3.org/2001/XMLSchema#string

Joseph E Parisi

http://www.w3.org/2001/XMLSchema#string

Raul N Mandler

http://www.w3.org/2001/XMLSchema#string

Richard M Ransohoff

http://www.w3.org/2001/XMLSchema#string

Wolfgang Bruck

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils

Cloning, expression, and characterization of the human eosinophil eotaxin receptor

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

The clinical course of neuromyelitis optica (Devic's syndrome).

Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils.

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

Regulation of antibody responses via antibodies, complement, and Fc receptors.

Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases.

P304

1450-1461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWF151

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 7

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Dorian B McGavern

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12076996

http://www.w3.org/2001/XMLSchema#string

P921

P932

5444467

http://www.w3.org/2001/XMLSchema#string